A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

456

Participants

Timeline

Start Date

March 25, 2024

Primary Completion Date

May 1, 2026

Study Completion Date

May 1, 2026

Conditions
Major Depressive Disorder
Interventions
DRUG

SP-624

Once daily oral administration of two capsules totaling 20 mg/day

DRUG

Placebo

Once daily oral administration of two matching placebo capsules

Trial Locations (48)

10016

Pioneer Clinical Research, New York

11229

Integrative Clinical Trials, Brooklyn

27511

Magnolia Clinical Research, Cary

27599

UNC Chapel Hill, Chapel Hill

28211

New Hope Clinical Research, Charlotte

29405

Coastal Carolina Research Center, North Charleston

30328

Accelerated Enrollment Solutions, Atlanta

32256

Clinical Neuroscience Solutions, Jacksonville

32801

Clinical Neuroscience Solutions, Orlando

33016

Segal Trials - Miami Lakes, Miami Lakes

33319

Segal Trials, Lauderhill

33782

DMI Research, Pinellas Park

33803

Accel Clinical, Lakeland

38119

Clinical Neuroscience Solutions, Memphis

44122

Velocity Clinical Research, Beachwood

44130

North Star Medical Research, Middleburg Heights

45417

Midwest Clinical Research Center, Dayton

60123

Revive Research Institute, Elgin

68526

Alivation Research, Lincoln

70072

Tandem Clinical Research, Marrero

72022

SanRo Clinical Research Group, Bryant

75080

Pillar Clinical Research, Richardson

75231

Future Search Trials of Dallas, Dallas

76309

Grayline Research Center, Wichita Falls

77477

R and H Clinical Research, Stafford

78737

Donald J. Garcia, Jr, MD, PA, Austin

79902

Haracec Clinical Research, El Paso

80910

MCB Clinical Research Centers, Colorado Springs

83642

Velocity Clinical Research, Meridian

85012

IMA Clinical Research, Phoenix

85704

Noble Clinical Research, Tucson

87109

IMA Clinical Research, Albuquerque

89102

IMA Clinical Research, Las Vegas

89119

Redbird Research, Las Vegas

90504

Collaborative Neuroscience Research, Torrance

90706

Clinical Innovations, Bellflower

91790

Next Level Clinical Trials, West Covina

91945

Synergy San Diego, Lemon Grove

92056

Excell Research, Oceanside

92251

Sun Valley Research Center, Imperial

92506

CiTrials, Riverside

94549

Sunwise Clinical Research, Lafayette

97210

Summit Headlands, Portland

98007

Northwest Clinical Research Center, Bellevue

98201

Core Clinical Research, Everett

02131

Boston Clinical Trials, Boston

08002

Center for Emotional Fitness, Cherry Hill

08053

CenExel HRI, Marlton

All Listed Sponsors
collaborator

Rho, Inc.

INDUSTRY

lead

Sirtsei Pharmaceuticals, Inc.

INDUSTRY

NCT06254612 - A Study of the Efficacy and Safety of SP-624 in the Treatment of Adults With Major Depressive Disorder | Biotech Hunter | Biotech Hunter